Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Montpellier
About this trial
The aim of assessing and managing cardiovascular risk is to avoid, limit or delay cardiovascular morbidity and mortality. Planned internal medicine hospitalization is developed around the management of cardiovascular risk in patients at high cardiovascular risk, whether in primary prevention or secondary prevention.
During planned hospitalization, patients benefit from comprehensive, personalized and adapted care for their comorbidities and their CVRF (cardiovascular risk factors).
This study will make it possible to evaluate this overall course of multidisciplinary management of comorbidities of patients at high cardiovascular risk.
Eligibility criteria
Qualifiers
Primary prevention because they have never had a cardiovascular event but have several cardiovascular risk factors such as high blood pressure particularly resistant, metabolic syndrome, diabetes , dyslipidemia, metabolic steatosis
Or secondary prevention because they have already had a major cardiovascular event such as ischemic heart disease, heart failure
Aged 18 and over
Patient benefiting from comorbidities assessment during their planned hospitalization in the internal medicine department.
Disqualifiers
Patient refusal
Subject not registered in social security system
Pregnant or breastfeeding woman
Patient unable to give their informed consent, protected adult, vulnerable people
Trial design
Treatments tested in this trial
- Screening and management of cormobidities
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov